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Acetylcholine (ACh) is a neurotransmitter acting via muscarinic and nicotinic receptors that
is implicated in several cognitive functions and impairments, such as Alzheimer’s disease.
It is believed to especially affect the acquisition of new information, which is particularly
important when behavior needs to be adapted to new situations and to novel sensory
events. Categorization, the process of assigning stimuli to a category, is a cognitive func-
tion that also involves information acquisition. The role of ACh on categorization has not
been previously studied. We have examined the effects of scopolamine, an antagonist
of muscarinic ACh receptors, on visual categorization in macaque monkeys using famil-
iar and novel stimuli. When the peripheral effects of scopolamine on the parasympathetic
nervous system were controlled for, categorization performance was disrupted following
systemic injections of scopolamine. This impairment was observed only when the stimuli
that needed to be categorized had not been seen before. In otherwords, themonkeyswere
not impaired by the central action of scopolamine in categorizing a set of familiar stimuli
(stimuli which they had categorized successfully in previous sessions). Categorization per-
formance also deteriorated as the stimulus became less salient by an increase in the level
of visual noise. However, scopolamine did not cause additional performance disruptions
for difﬁcult categorization judgments at lower coherence levels. Scopolamine, therefore,
speciﬁcally affects the assignment of new exemplars to established cognitive categories,
presumably by impairing the processing of novel information. Since we did not ﬁnd an
effect of scopolamine in the categorization of familiar stimuli, scopolamine had no signiﬁ-
cant central action on other cognitive functions such as perception, attention, memory, or
executive control within the context of our categorization task.
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INTRODUCTION
The nervous system is adaptive, so that its neuronal properties can
be modiﬁed by learning to respond to new categories of stimuli.
Acetylcholine (ACh) is one of several neuromodulators implicated
in several cognitive functions. The nucleus basalis of Meynert
(NBM) supplies the non-intrinsic cholinergic input to the neo-
cortex and shows marked cell loss in Alzheimer’s patients (Perry,
1988; Levy, 1996) and in other cognitive disorders, for example
Wernicke–Korsakoff syndrome (Arendt et al., 1983; Savage et al.,
1999) and Creutzfeldt–Jakob disease (Arendt et al., 1984). Indeed
ACh is believed to play an important role in many cognitive func-
tions, including attention (Voytko et al., 1994; McGaughy et al.,
1996; Sarter and Bruno, 2000; Furey et al., 2008; Herrero et al.,
2008; Deco and Thiele, 2010), signal detection (Sillito and Kemp,
1983; Zinke et al., 2006; Goard and Yang Dan, 2009), cue detec-
tion (Parikh and Sarter, 2008), decision-making (Roberts et al.,
1990), learning (Richardson and DeLong, 1988; Roberts et al.,
1990; Sarter et al., 2003), memory encoding (Bakin and Wein-
berger, 1996; Miasnikov et al., 2001, 2008, 2009;Weinberger, 2003)
short-term memory (Miller and Desimone, 1993; Fransen et al.,
2006; Plakke et al., 2008; Thomas et al., 2008), and long-term
memory retrieval (Rosier et al., 1999; Sarter et al., 2003).
Considering the variety of cognitive functions affected by
acetylcholine, the question arises whether some functional
speciﬁcity can be ascribed to its action. Several studies have tried
to dissect the exact system that scopolamine affects, as an effect
on one cognitive system can inﬂuence others. It has been hypoth-
esized that the cortical cholinergic inputs optimize the processing
of signals in attention-demanding contexts (Sarter et al., 2005).
Similarly, it has been also hypothesized that cortical cholinergic
inputs are involved in the mediation of top-down effects such
as the knowledge-based augmentation of “detection of signals,”
deﬁned according to Posner as the awareness or behavioral report
of signals (Posner, 1980; Posner et al., 1980). Actions speciﬁcally
through muscarinic ACh receptors have been linked to attentional
mechanisms (Ruotsalainen et al., 2000). In addition, or in con-
trast, to the hypothesis of a role in attention, there is considerable
evidence for the involvement of muscarinic receptors in visual
recognition using delayed non-match to sample (DNMS) tasks.
The muscarinic antagonist scopolamine affects the encoding of
new information into long-term memory using the Wisconsin
General Test Apparatus (Ridley et al., 1984) and reduces the choice
accuracy in stimulus-recognition memory forgetting tasks (e.g.,
DNMS, Aigner and Mishkin, 1986). However, increased forget-
ting is not dependent on retention interval (Aigner and Mishkin,
1986) which has also been interpreted as an impediment in the
entrance of information into memory, i.e., memory encoding or
memory storage (Taffe et al., 1999). Another DNMS study by
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Aigner et al. (1991) argued that initial storage but not long-term
memories, attentive or perceptual processes are affected by scopo-
lamine, because the monkeys were not affected when injected after
acquisition. A study by Myers et al. (2002) suggested up to a
40% drop in DNMS performance following scopolamine injec-
tions while in a different study there was approximately a 12%
performance drop in a DNMS task after scopolamine injection in
perirhinal cortex (Tang et al., 1997). A similar deﬁcit with imme-
diate and delayed word recall was seen in human subjects (Ebert
et al., 1998). There seems, therefore a relative consensus to have
emerged that ACh affects cognition when behaviorally signiﬁcant
or novel stimuli need to be processed (Pepeu and Giovannini,
2004).
Nonetheless, even within this context there has been some
debate. For example the study of Voytko et al. (1994) attributed a
role in attention to ACh, and more speciﬁcally to the NBM cholin-
ergic projection, rather than in learning and memory, based on
negative results in a variety of mnemonic tasks. In a separate exper-
iment, the authors interpreted the decrease in correct performance
under scopolamine also as an effect of attention, while there was
no direct comparison between novel and familiar stimuli, a poten-
tial confound when attributing the deﬁcit to attention. A role of
ACh in attention has received widespread support among other
researchers (e.g., Sarter and Parikh, 2005; Hasselmo and Sarter,
2011) based partly on its role in signal detection (Herrero et al.,
2008; Deco and Thiele, 2010).
In contrast to these studies that attempted to deﬁne a speciﬁc
function affected by scopolamine, a more recent study in humans
claimed an effect on a variety of cognitive functions including
perception, attention, learning, short-term memory, and even
recall (Fredrickson et al., 2008). This particular study, however,
despite its other advantages, failed to use a control for the periph-
eral actions of scopolamine, making interpretation of the results
difﬁcult, since autonomic depression can impair psychomotor
function, attention, and memory recall (Heims et al., 2006).
Categorization involves many cognitive functions that include
the perception of a stimulus, motivational state, learning, and its
executive allocation to a category. We have examined the effects
of scopolamine, an antagonist of muscarinic ACh receptors, on
visual object categorization in macaques. An important control
in this design was the comparison of categorization performance
between novel stimuli and familiar stimuli. If scopolamine had an
effect in a variety of cognitive functions other than the categoriza-
tion speciﬁcally of novel stimuli, then the categorizationof familiar
stimuli should be affected (e.g., due to effects in perception, atten-
tion, motivational state, decision, and long-term memory recall,
etc.). An additional crucial control was the use of an analog of
scopolamine that does not cross the blood brain barrier, in order
to dissect the direct cognitive effects through the central action
from any indirect effects due to scopolamine’s actions on the
parasympathetic system.
MATERIALS AND METHODS
SUBJECTS AND PHARMACOLOGICAL TREATMENTS
The experiments described here were carried out in accor-
dance with the EC Directive 86/609/EEC for animal experiments.
Two adult male macaques (K03, 12.5 kg, 11 years of age and
D07, 14.5 kg, 8 years of age) were trained in a categorization
task: to classify stimuli into categories by appropriate behavioral
responses. The paradigm involved a task during which an image
that belonged to one of the categories was presented. The macaque
used levers to categorize the stimulus. Images were presented at
the center of ﬁxation once the macaque pressed a pair of levers
for 500 ms. The images remained on the screen for 200 ms after
which period a light gray cue square was presented for 1200 ms
(Figure 1). While the cue square was present, the monkeys could
release one of the levers to indicatewhich category had been shown
and, if correct, obtain a juice reward.
On alternate days the macaque received s.c. (subcutaneously)
either an injection of scopolamine in 1 ml saline or the vehicle.
For example, if a scopolamine injection was made on a Monday,
a saline injection would be made on Tuesday. Scopolamine was
delivered at 7.5 or 10μg/kg. These doses are similar to those used
in human studies (Fredrickson et al., 2008) and in previous studies
of rhesus macaques (Taffe et al., 1999; Myers et al., 2002; Plakke
et al., 2008). In pilot experiments, lower doses of 5μg/kg caused
drowsiness while higher doses (15μg/kg) caused some agitation.
Testing began ½ h to 1 h after injection.
Scopolamine can cross the blood brain barrier, however it can
also cause parasympathetic depression peripherally which could
affect either the perception of the stimuli or performance due to
some non-speciﬁc effects. For example, scopolamine causes pupil-
lary dilation, depression of salivation, suppression of pharyngeal
motility, (hence food and juice ingestion) and suppression in the
secretion of gastric ﬂuids. In principle, changes in task perfor-
mance could be centrally mediated and/or peripherally mediated.
Butyl-scopolamine, an analog of scopolamine that does not cross
the blood brain barrier, was therefore administered as a control,
to determine the extent to which the peripheral actions of scopo-
lamine affected performance in the categorization task. Pupillary
dilation was used as a bioassay to titrate the effective dose of butyl-
scopolamine at the same level as the doses of scopolamine used
in this study. This was achieved with butyl-scopolamine doses of
4.0–6.0 mg/kg.
FIGURE 1 | Categorization task. After successfully ﬁxating on a central
ﬁxation spot and concurrently pressing two levers for 500ms, a stimulus
was presented for 200ms. Immediately afterward, a light gray response
cue was presented for 1200ms during which the macaque had the
opportunity to categorize the previously seen image as a “ﬂower” or a
“monkey” by releasing the appropriate lever.
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Experiments under butyl-scopolamine started 3 weeks after
the end of the scopolamine experiments in the case of D07 and
5 months after the scopolamine experiments in the case of K03.
In statistically comparing the difference in performance of scopo-
lamine from butyl-scopolamine in these two separate periods, we
have normalized the performance against the saline experiments
carried out on the day before or after each drug experiment. There-
fore what is compared in Table 2 and the related statistics is the dif-
ference in task performance under scopolamine vs. saline from the
difference in task performance under butyl-scopolamine vs. saline.
STIMULI AND CATEGORIZATION TASK
The size of the visual stimulus presented in the categorization
task was 6˚ of visual angle and the ﬁxation window was 12˚.
Grayscale stimuli normalized for equal luminance (mean grayscale
value= 128), equal contrast, and amplitude spectrum were pre-
sented at the center of a computer screen. The luminance of the
screen without the stimuli was 7.0 cd/m2, whereas the mean lumi-
nance of the stimuli themselves was 17.8 cd/m2. The equivalent
reﬂectances were for the screen 3.0e−2 W/sr.m2 and for the stimuli
7.2e−2 W/sr.m2. The stimuli used for the experiment were natural
scenes that belonged to either of two categories: monkeys or ﬂow-
ers. The monkey images included in all sessions both macaque
and non-macaque images, faces, whole animals, and groups of
animals. The ﬂowers were an even mix of radially symmetrical,
irregular (e.g., orchids), or several ﬂowers per image at a variety
of orientations. The aim was to train the monkeys to use as far as
possible true category and not a lower level feature such as a facial
feature or radial symmetry.
It has been hypothesized that the cortical cholinergicACh input
is critical in difﬁcult perceptual judgments and optimizes the pro-
cessing of signals in attention-demanding contexts (Sarter et al.,
2005). To improve the probability of seeing an effect of scopo-
lamine on categorization, the images were, therefore, parametri-
cally interpolated with random phase“masks”using a degradation
procedure we have used previously (Rainer et al., 2004; Liebe et al.,
2009). As individual natural images contain characteristic corre-
lated phase spectra, the procedure increased the noise (i.e., reduced
the coherence or phase correlation) of the stimuli (Figure 2). The
aim was to introduce graded levels of salience. The levels used were
100,60,55,50,45,40,and0%coherence,with 100%corresponding
to the coherent intact image (after equalization) and 0 to complete
noise. We chose this range of coherence because pilot studies had
indicated that the macaques had a threshold in their ability to
recognize the images in the region of noise levels 40–50. Outside
this range, with less noise (over 50% stimulus coherence) the ani-
mals performed as well as with the 100% intact image whereas
with more noise (under 40% stimulus coherence) their responses
were at chance. Every time an image appeared at a given coherence
level it was interpolatedwith a new randomphasemask, so that the
image never was quite the same when presented again at the same
coherence level. This procedure was introduced so as to avoid a
strategy of using diagnostic elements of a stimulus (Nielsen et al.,
2006) rather than stimulus category to categorize the images.
The monkeys were trained over several months on a set of six
ﬂower and six monkey images (Figure 3), which became familiar
to them. During testing, in addition to these 12 familiar stimuli,
a set of 12 novel stimuli (six monkey and six ﬂower) was also
presented. The set of novel stimuli changed every day. The cat-
egorization task performed by the monkey involved a stimulus
presentation generated atwill by themonkey’s action of depressing
both levers while ﬁxating for 500 ms at a ﬁxation spot at the center
of a computer screen. Stimuli were presented randomly from the
set of 12 ﬂower and 12 monkey stimuli at one of the seven coher-
ence levels for 200 ms. Following image presentation, the monkey
had a period of 1200 ms to categorize the image by releasing one
of the levers, left for monkey, or right for ﬂower. Once trained,
the monkeys could complete their responses within 600 ms even
under scopolamine. Less than 0.5% of their responses had laten-
cies greater than 600 ms. Thus the 1200 ms response window was
not restricting their performance.
There were 11 experiments with scopolamine (seven with D07
and four with K03) and nine experiments with butyl-scopolamine
(three with D07 and six with K03). Since experiments with only
saline were carried out on alternate days, there were 40 test days in
total. Minimum intervals were 2 days between scopolamine injec-
tions and 3 days between butyl-scopolamine injections. Butyl-
scopolamine experiments began about 3 weeks after the end of the
scopolamine experiments to avoid releasing through competitive
antagonism scopolamine still bound in the organism. There was a
single injection per day and testing began 30 min after injection.
Monkeys performed at least 1100 complete trials per day, that is tri-
alswhen themonkeys respondedwithin 1200 msof theonset of the
response cue (range: 1138–2478 trials). Approximately half of the
trials were with novel and half with familiar stimuli, half and half
in each category, apportioned into the seven coherence levels. The
presentation of the stimuli was randomized with respect to famil-
iarity, category, and coherence, only constrained by a condition
FIGURE 2 | Parametric interpolation with random phases of one monkey and one flower exemplar. Numbers on top of each image refer to % coherence.
At 0 level, the image therefore contains only noise.
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FIGURE 3 | Set of 12 familiar stimuli (100% coherence).
that by 1680 trials responses were required from the monkey for
840 stimuli in each category and each familiarity level, with 240
stimuli in each coherence level. So by 1680 trials, 60 responses
were required for every combination of category, familiarity, and
coherence level.
STATISTICAL ANALYSIS OF BEHAVIORAL DATA
For each experiment, psychometric functions were computed in
which the proportion of correct responses was plotted against the
noise level for each of the four conditions: familiar or unfamiliar
stimuli with or without scopolamine using the psigniﬁt routine
(Wichmann and Hill, 2001a,b). The same procedure was used to
ﬁt behavioral performance under butyl-scopolamine. Conﬁdence
limits were computed and a univariate ANOVA was performed
(factors: subject, treatment, familiarity, coherence). ANOVAs were
carried out both for the probability of a correct response and for
latency of response. Response latencies were calculated from the
time the stimulus was turned off and the response cue came on,
when the macaques could respond by releasing one of the levers.
In some experiments one of the monkeys used a strategy of
releasing the levers at random or mostly at random, which would
still allow him to obtain reward 50% of the time. To avoid poten-
tial confounds, if performancewas impaired during an experiment
to less than 60% average correct for the highest coherence levels,
the experiments (three experiments) were not used for further
analysis, other than for the response latency measurements.
RESULTS
The results are presented in three subsections. The effects of
scopolamine on categorization performance with either saline or
butyl-scopolamine as a control are presented in the ﬁrst sub-
section. To assess the effects of scopolamine on categorization
performance, psychometric functions were calculated, and we
compared the effects of the drug/control on the proportion of cor-
rect responses using analysis of variance and associated statistical
analyses. The main ﬁnding was that categorization of novel stimuli
was impaired in both subjects whereas scopolamine had no effect
on the categorization of familiar stimuli. In the second subsection,
categorization response latencies are compared with or without
scopolamine. The effects of scopolamine on other observed para-
meters, such as pupil dilation and juice consumption,are presented
in the third subsection.
CATEGORIZATION PERFORMANCE
In both monkeys, scopolamine impaired the categorization of
novel stimuli, when categorization performance was compared
to performance following injection of saline (Figure 4). A
four factor ANOVA was carried out (Table 1). Factors were 1.
Stimulus coherence (six levels), 2. Drug treatment (scopolamine,
butyl-scopolamine or saline), 3. Familiarity (novel or familiar), 4.
Subject: D07 or K03.
Therewas a very highly signiﬁcantANOVA[F(95,408)= 40.34,
p = 3.689e−157]. Additionally, there was a very highly signiﬁcant
interaction of drug treatment × familiarity which indicates that at
least one of the drugs affected performance for at least one of the
familiarity levels (indeed for the novel stimuli, as will be seen fur-
ther down). The treatment× familiarity× coherence interaction
was not signiﬁcant [F(15, 408)= 66.74, p = 0.072]. It can be con-
cluded that not only familiarity and drug treatment but also their
interactionwere independent of coherence. Therefore, as indicated
also by the presence of a downward rather than a rightward shift
of the psychometric curve, perceptual sensitivity remained similar
but categorization performance changed.
Data satisﬁed the normality requirements for ANOVA (using
Kolmogorov–Smirnov and Shapiro–Wilk tests) but overall did
not satisfy equality of variances [Levene’s test, F(95,408)= 2.291,
p = 1.12e−8]. For that reason, three post hoc tests were selected to
assess the results of the ANOVA that do not assume equality of
variances: the Games-Howell, Dunnet T3, and Tamhane post hoc
tests. All three post hoc tests gave the same level of signiﬁcance for
all comparisons.
Paired t -tests also conﬁrmed that scopolamine and butyl-
scopolamine affected categorization differently for familiar vs.
novel stimuli (Table 2). Speciﬁcally, scopolamine but not butyl-
scopolamine impaired the categorization of novel stimuli,whereas
in the case of the categorization of familiar stimuli, the effects of
scopolamine andbutyl-scopolaminewere not statistically different
according to the post hoc testing (although paired t -tests suggested
a difference). Post hoc testing also pointed out that the highest
three stimulus coherence levels (55, 60, and 100% coherence) were
homogeneous and did not differ statistically from each other.
How much greater was the impairment under scopolamine
to that caused by butyl-scopolamine alone (due to its peripheral
actions)? Since the highest three coherence levels were statistically
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homogeneous, we used these three levels to quantify the rela-
tive effect size of scopolamine on categorization performance in
the two monkeys, by calculating the difference in performance
between scopolamine vs. saline and butyl scopolamine vs. saline
for the three highest coherence levels (Table 1). We carried out
a new ANOVA with the difference between the two drugs as
the dependent variable (Table 2). The results indicated that the
FIGURE 4 | Average psychometric functions of the behavioral
performance for the two monkeys, (A) Effect of scopolamine on the
performance of the categorization task for monkey. D07 (seven
scopolamine experiments, 7.5–10μg/kg dose) and monkey K03 (four
scopolamine experiments, 7.5μg/kg dose). On theY axis is plotted the
proportion of correct responses (probability of a correct response,
mean±1SE). The color coding scheme is indicated in the lower right. Both
animals showed worst performance when categorizing novel images under
scopolamine. (B) Butyl-scopolamine experiments: performance under
butyl-scopolamine (2–4mg/kg), a scopolamine analog that cannot cross the
blood brain barrier (three and six experiments, respectively). Experiments
within a panel consist of scopolamine and control experiments on
successive days whereas comparisons between panels involve
experiments spaced potentially weeks or months apart.
factor familiarity had a very highly signiﬁcant effect [ANOVA,
F(1, 118)= 31.07, p = 1.60e−7] as did the factor “treatment,” i.e.,
whether the monkeys received scopolamine or butyl-scopolamine
[F(1, 118)= 60.25, p = 3.35e−12]. This effect did not depend on
the subject (monkey) as there were no signiﬁcant interactions
between subject× familiarity or subject× treatment. This analy-
sis also conﬁrms the conclusions of our earlier ﬁndings from the
ANOVA with all six coherence levels. A summary of these results
is presented in Figure 5. The comparisons of drug vs. saline are
plotted in Figure 5A and the comparisons of scopolamine vs.
butyl-scopolamine in Figure 5B. Compared to butyl-scopolamine,
scopolamine led to an overall 11.4% impairment for monkey K03
and an overall 15.4% impairment for monkey D07 in the cat-
egorization of novel stimuli (with 50% impairment in correct
performance as the maximum). It can be concluded that both
monkeys were most impaired, in relation to pharmacological con-
trols,when they had to categorize novel stimuli under scopolamine
(Figures 4,5).
RESPONSE LATENCY
In addition to the effect of scopolamine on the proportion
of correct trials, scopolamine affected the latency of the ani-
mals’ responses in the task (Figure 6). Without scopolamine,
average response latency for the 100% coherence stimuli was
309± 9 ms (mean± SE) for monkey D07 and 304± 12 ms
(mean± SE) for monkey K03. The latency of response to the
stimuli, when a correct response was made, was inversely cor-
related with coherence and was longer for novel stimuli, presum-
ably a case of speed-accuracy trade-off. Scopolamine increased
response latency compared to saline in both monkeys, D07
[ANOVA, F(1,140)= 8.922, p = 0.00333] and K03 [ANOVA,
F(1,140)= 16.483, p = 8.132e−5]. Scopolamine’s effect in increas-
ing response latency was not speciﬁc for novel stimuli and could
reﬂect its role in cue detection and executive processes.
Indeed, no factor interactions were signiﬁcant; despite an over-
all trend,one could not argue that scopolamine delayed speciﬁcally
the categorization of novel stimuli. InmonkeyD07,however,when
only the three most coherent levels were used for the ANOVA, the
scopolamine× familiarity interaction was highly signiﬁcant. The
latency for the categorization of novel stimuli under scopolamine
Table 1 | Paired t -tests of categorization performance of drug treatment (scopolamine or butyl-scopolamine) vs. saline (paired experiments
were conducted on alternate days).
Dependent variable: proportion correct Paired differences df t Sig. (two-tailed)
Mean SE
D07 scop nov – D07 sal nov −10.8306122 1.157665 48 −9.35556 2.14E-12***
D07 scop fam – D07 sal fam −1.04897959 0.601105 48 −1.74508 0.08737
D07 butylscop nov – D07 sal nov −0.39285714 1.653239 27 −0.23763 0.813963
D07 butylscop fam – D07 sal fam 0.471428571 0.893374 27 0.527694 0.602022
K03 scop nov – K03 sal nov 9.903571429 2.031423 27 4.875189 4.26E-05***
K03 scop fam – K03 sal fam −5.9 1.890123 27 −3.12149 0.004257**
K03 butylscop nov – K03 sal nov −4.08571429 1.125208 41 −3.63108 0.000777***
K03 butylscop fam – K03 sal fam −1.72857143 1.317316 41 −1.31219 0.196755
D07 and K03 were the two macaques; scop, scopolamine; butyl-scop, butyl-scopolamine; sal, saline; nov, novel stimuli; fam, familiar stimuli. **p<0.01; ***p<0.001.
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Table 2 |Three-factor univariate ANOVA of correct categorization
performance dependent variable: difference in performance
(drug–saline) treatment factor: two levels: scopolamine or
butyl-scopolamine.
Source df F Sig.
Corrected model 7 21.34863 2.26E-18***
Intercept 1 134.7247 3.04E-21***
Subject 1 15.51269 0.000139***
Familiarity 1 31.07237 1.6E-07***
Treatment 1 60.24616 3.35E-12***
Subject× familiarity 1 3.043932 0.083643
Subject× treatment 1 1.859905 0.175232
Familiarity× treatment 1 29.66078 2.85E-07***
Subject× familiarity× treatment 1 1.670446 0.198724
Error 118
Total 126
***p<0.001.
FIGURE 5 | Mean percent impairment of performance for each monkey
for the categorization of familiar or novel stimuli compared to control.
The means of the three highest coherence levels have been used in making
these comparisons. The colors of the bars match the colors of the curves in
Figure 4, other than that the control in this case is not saline but
butyl-scopolamine. (A) Mean percent performance change (Mean±SE) of
drug treatment relative to saline. Positive values are for impairment,
negative values for improvement. The categorization of novel stimuli was
signiﬁcantly impaired by scopolamine compared to the other treatments
which were not signiﬁcantly different from each other in either monkey. (B)
Effect on performance due to the central action of scopolamine: mean
percent impairment due to scopolamine after subtracting the mean
impairment due to butyl-scopolamine, the peripherally acting analog. On
the basis of the result shown in (A), the impairment in the categorization of
the familiar stimuli is not signiﬁcant in either monkey. The categorization of
novel stimuli but not of familiar stimuli was signiﬁcantly impaired by the
central actions of scopolamine, based on the butyl-scopolamine control.
Statistics in the text.
was longer for coherence level 100 (ANOVA p = 0.009, paired t -
test p = 0.005), also for coherence level 60 (ANOVA p = 0.009,
paired t -test p = 0.006) and it was signiﬁcant for coherence level
55 (ANOVA p = 0.009, paired t -test p = 0.013). Response latency
was shortest when familiar stimuli had to be categorized after
injection of saline (Figure 6).
FIGURE 6 | Response latencies under the four different conditions at
the seven different coherence levels. Response is measured from the
time the stimulus is presented to the time the appropriate lever is released
and is shown here for the correct responses only. In monkey D07
(scopolamine drug injections 7.5 and 10μg/kg combined), response
latencies were shorter for the more coherent stimulus levels (ANOVA,
p<1.96e−14). Scopolamine signiﬁcantly slowed categorization responses
for novel stimuli at the more coherent levels (55–100) as compared to
categorizing the novel stimuli after injection of saline, while the
categorization of familiar stimuli under saline was generally the fastest. In
monkey K03 response latencies were also shorter for the more coherent
stimulus levels (ANOVA, p< 6.81e−15) at the 7.5μg/kg dose level.
SCOPOLAMINE EFFECTS ON OTHER OBSERVED PARAMETERS
In addition to its effects on the categorization task, ACh has
a variety of other effects. We measured several other para-
meters that in D07 included pupil diameter, total number
of valid trials, percentage of aborted trials, and total volume
of juice consumed. Pupil diameter was signiﬁcantly increased
by scopolamine (paired t -test p = 0.00012, n = 7), total num-
ber of valid trials was reduced (paired t -test p = 0.0008,
n = 7), percentage of aborted trials following successful ﬁxa-
tion was increased (paired t -test p = 0.0074, n = 7), response
latency to the non-degraded stimuli was increased (paired t -
test p = 0.0013, n = 7), experiment duration (hours the monkey
worked per day) was increased (paired t -test p = 0.00013, n = 7),
and volume of juice consumed was reduced (t -test p = 0.016,
n = 7).
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Some of these parameters were similarly affected by the periph-
eral agonist butyl-scopolamine: pupil diameter was signiﬁcantly
increased (paired t -test p = 0.0040, n = 4), total number of valid
trials was reduced (paired t -test p = 0.0038, n = 4). Percentage
of aborted trials following successful ﬁxation was unchanged
(paired t -test p = 0.73, n = 4), response latency was unchanged
(paired t -test p = 0.66, n = 4), experiment duration was affected
but not signiﬁcantly (paired t -test p = 0.25, n = 4), and volume of
juice consumed was reduced but not signiﬁcantly (t -test p = 0.38,
n = 4). These effects were, therefore, similar with both drugs.
They can best be explained therefore as the result of peripheral
parasympathetic depression. Nevertheless, after subtracting the
impairment in performance caused by butyl-scopolamine from
that caused by scopolamine (e.g., Figure 5) it can be concluded
that the central action of scopolamine on the categorization of
novel stimuli was independent of peripheral side effects such as
pupillary dilation.
DISCUSSION
We have examined the effects of scopolamine, an antagonist of
muscarinic ACh receptors, on visual categorization in macaques.
In both animals scopolamine impaired performance in the catego-
rization of novel stimuli, while impairment on the categorization
of familiar stimuli was non-signiﬁcant in both animals, when the
peripheral actions of this drug were controlled for. This ﬁnding
suggests a special role of muscarinic cholinergic mechanisms in
the categorization of novel visual information.
Our ﬁnding complements previous studies ﬁnding a role for
acetylcholine in the processing of novel information. Ridley et al.
(1984) foundno effect of scopolamine on visual discriminations of
very familiar objects.Aigner et al. (1987) have proposed that recog-
nition memory (familiarity) is affected by lesions in the NBM,
whileWilson and Rolls (1990a) found neurons in the primate sub-
stantia inominata (including the NBM) with differential responses
between novel and familiar stimuli. Other studies have implicated
the basal forebrain cholinergic region in reward associations (Rolls
et al., 1980, 1986;Wilson and Rolls, 1990b). Consequently,Masuda
et al. (1997) have argued in favor of cholinergic mechanisms of
object–reward associations with novel or familiar stimuli in the
cholinergic groups of the basal forebrain whose function would
have been impaired by scopolamine in our study.
It must be noted that the task the monkeys performed was
under executive cognitive control, such that the stimuli appeared
on command, following a voluntary depression of the two levers.
The monkey did not have to wait for a cue. The cognitive task
required only attention to the stimulus itself, while the stimu-
lus was generated at will. Therefore any effects of scopolamine
on cue detection and cue-based attention as reported in the lit-
erature (see Hasselmo and Sarter, 2011) were bypassed. In this
situation, the lack of impairments on the categorization of famil-
iar stimuli suggests that non-cue-driven attention was not affected
by scopolamine.
Similar conclusions can be drawn when considering the central
effect of scopolamine in impairing performance only for novel
stimuli. The implication is that scopolamine did not generally
affect attentional mechanisms, perception, decision-making, or
basic neuronalmechanisms inways detrimental to performing this
task. The action of scopolamine decreased percent correct perfor-
mance for novel stimuli beyond any effects caused by the peripher-
ally acting analog butyl-scopolamine, which caused as in the case
of a study by Ruotsalainen et al. (2000) an increase in omissions
(aborted trials), decrease in the total number of trials completed,
and an increased response latency. Additionally, scopolamine
affected the categorization of novel stimuli across all coherence
levels, indicating a speciﬁc learning impairment possibly through
an impairment in the acquisition of new information and the
storage of new memories. The scopolamine-induced impairment
appears to be associated with the categorization of novel stim-
uli, rather than being a non-speciﬁc effect attributable to difﬁcult
perceptual judgments, as it was present at all coherence levels.
The speciﬁc effect of scopolamine only on the processing of
novel stimuli indicates that the effect of scopolamine on object
recognition observed in previous studies (Tang et al., 1997; Myers
et al., 2002) may be due to an effect on memory encoding rather
than due to effects on other cognitive functions such as perception,
memory retrieval, decision, or reporting (since the categoriza-
tion of familiar stimuli was unaffected). This conclusion is in
agreement with the conclusions of the Wisconsin General Test
Apparatus of Ridley et al. (1984) and the DNMS study by Aigner
et al. (1991), that scopolamine has an effect on learning by impair-
ing the encoding of new information in long-term memory. Our
ﬁndings are also in agreement with the conclusion of Dotigny et al.
(2008) that scopolamine does not affect visual acuity in rats, lead-
ing the authors to conclude that their study indicates that the basal
forebrain cholinergic system is involved in cognitive enhancement
or attention during visual learning. Our ﬁndings also agree with
the conclusion of Miller and Desimone (1993) that scopolamine
had no effect on the sensory information conveyed by IT neurons.
There are a number of possibilities based on the literature about
the exact involvement of the cholinergic system. One possibil-
ity is that scopolamine impairs synaptic plasticity mechanisms
facilitated by acetylcholine. For example, activation of muscarinic
receptors is required for the induction of corticostriatal long-term
potentiation (LTP; Calabresi et al., 1999) and perirhinal long-term
depression (LTD; Warburton et al., 2003), actions that can be
blocked by scopolamine. Indeed the block of LTD in higher visual
area TE of the rat (Warburton et al., 2003) suggests that one role of
the cholinergic system may be the acquisition and storage of new
information such that novel stimuli may become “familiar.” This
ﬁnding may explain the increased responsiveness under scopo-
lamine of IT neurons to sample stimuli in a DMS task observed by
Miller andDesimone (1993). Scopolaminewould block the LTD to
novel stimuli (only) and therefore neurons in the IT and perirhi-
nal cortex would be expected to have a higher ﬁre rate response to
the presentation of novel stimuli (as novel samples in a DMS task)
under scopolamine, one of the ﬁndings of that study. Additional
evidence that ACh is involved in synaptic plasticity is available
from studies in the hippocampus (Drever et al., 2011). Endoge-
nous ACh lowers the threshold for LTP in the hippocampus via
a muscarinic receptor dependent mechanism (Ovsepian, 2008). If
Hebbian synaptic modiﬁcation mechanisms are involved, there is
additional evidence that would implicate the temporal lobe as the
relevant locus. Cholinergic deafferentation of the perirhinal cortex
in the rat using saporin immunoglobulin lesions (McGaughy et al.,
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2005) and physical lesions to the input from the basal forebrain to
area TE and the perirhinal cortex in the macaque (Browning et al.,
2010) strongly suggest that object recognition, working memory,
and ultimately learning of stimulus reward associations involving
novel but not familiar objects depend on cholinergic mechanisms.
However, other loci may also be affected, especially as the catego-
rization task involved complex operant conditioning and there is
evidence that corticostriatal LTP, an area involved in operant con-
ditioning, depends on local striatal cholinergic activity (Calabresi
et al., 1999).
A second possibility is that scopolamine impairs input and gain
control in the brain andmore so for novel stimuli.A gain-changing
action has been hypothesized both for cortical sensory areas as
well as for the hippocampus (Sarter et al., 2005; Giocomo and
Hasselmo, 2007). This argument is similar to an old hypothesis
of a setting of an alert brain state by cholinergic drive (Grossman
et al., 1965). A dual mode of action of ACh indeed would involve a
combination of both of the above mechanisms (Ovsepian, 2008),
with modulation of synaptic plasticity to determine the relative
dominance of neuronal inputs while a generalized facilitation
of transmission might affect the overall gain for transmission
through cortical regions.
A third possibility, especially in relation to the role of the
NBM, is that scopolamine affects the categorization especially of
novel stimuli via a block of a prefrontal drive (Rasmusson et al.,
2007). Cholinergic enhancement produced by the cholinesterase
inhibitor physostigmine eliminates the modulation of neural
activity by task-difﬁculty in the prefrontal cortex during working
memory (Furey et al., 2008). In such a case, there would be a loss of
task-difﬁculty dependent prefrontal drive. The NBM receives cor-
tical input only from the prefrontal and anterior temporal cortex
(Mesulam and Mufson, 1984; Grove, 1988; Gaykema et al., 1991)
and is a likely intermediary in the allocation of cortical resources
to a difﬁcult task. Therefore scopolamine would presumably block
the output of prefrontal drive that could allocate selected corti-
cal/attentional resources to a difﬁcult task, such as the detection
of the novel and often noisy stimuli in the categorization task
in the present experiments. The exact site of the effect of scopo-
lamine on the categorization task has not yet been established but
may indeed depend on forebrain mechanisms with a prefrontal
involvement.
It is clear from the fact that the monkeys could categorize novel
images with relative accuracy and well above chance, especially in
the absence of scopolamine, that the monkeys had learned cor-
rectly to form the categories for which they had been trained. The
experiment as designed cannot address satisfactorily the question
whether the effect of scopolamine was on learning about new
objects or on generalizing into better, more inclusive categories.
That some object-based learning of the images was involved is
expected by the indistinctness of the low-coherence stimuli. At
least when their coherence was around the psychophysical thresh-
old, information encoding, and short-term memory would be
required (Lewandowsky, 2011) and these are processes needed for
new object learning. Categorization, nevertheless, involves gener-
alizing over representations of several objects. The question can be
raised whether it was object learning or a generalization to novel
exemplars that was affected by scopolamine during this task.
Within this context, there are two hypotheses about how cat-
egorization operates, either via new exemplar learning or via the
application of categorization rules independent of new learning.
According to the ﬁrst view, categorization involves category gener-
alization analogous to the process of generalizing to several views
of the same object, similar to the mechanism of how object learn-
ing occurs (Logothetis and Pauls, 1995; Booth and Rolls, 1998).
The underlying associational mechanisms for object view gen-
eralization (object learning) and category object generalization
(category learning) may indeed be quite similar (Soto and Wasser-
man, 2010). There is evidence that categorization learning uses
image fragments qualitatively similar to those used in object learn-
ing (Hegdé et al., 2008; Kromrey et al., 2010) and that information
for both object identity and object category is available in the
same brain region, the IT cortex (see Sigala and Logothetis, 2002;
Buckley and Sigala, 2010). Nonetheless, our experiments were not
designed to discriminate between these two possible mechanisms
for categorization.
Notwithstanding the question of whether object or category
learning was impaired by scopolamine at the low-coherence levels,
categorization performance for novel stimuli remained impaired
even at higher coherence levels. The downward shift in the psy-
chophysical curve for the categorization of novel stimuli by scopo-
lamine tends to favor the interpretation that the antimuscarinic
action of scopolamine caused an impairment in categorization
at all levels. This would favor a role of acetylcholine in cortical
plasticity at levels (and cortical sites) located higher in the visual
hierarchy. Nevertheless, here the role of ACh could be analogous
to its role in plasticity of the tuning properties of primary sensory
neurons (e.g.,Bakin andWeinberger,1996;Kilgard andMerzenich,
1998; Warburton et al., 2003; Weinberger, 2003; Froemke et al.,
2007; Kang and Vaucher, 2009).
It must be concluded that already formed object and category
representations were unaffected by the antimuscarinic action of
scopolamine but that the monkeys were less able to assign novel
stimuli as further exemplars into pre-existing categories. It cannot
be ascertained on the basis of these results whether the stabil-
ity of categorization rules or internal “concepts” (Bruner et al.,
1967) is completely unaffected by muscarinic actions. However, it
is likely that already established object category rules and exem-
plars remained stable, as the categorization of familiar images was
not impaired by scopolamine.
CONCLUSION
In conclusion, scopolamine through its central antagonism of
muscarinic ACh receptors affected primarily the categorization
of novel stimuli. The process of visual categorization, and in par-
ticular the assignment of novel exemplars to a given category, can
be disrupted via an inhibition of central muscarinic receptors.
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